|
Natives Engaged in Alzheimers Research - 'Ike Kupuna
RECRUITINGN/ASponsored by University of Hawaii
Actively Recruiting
PhaseN/A
SponsorUniversity of Hawaii
Started2022-09-15
Est. completion2025-06-15
Eligibility
Age50 Years – 75 Years
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT05534607
Summary
This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.
Eligibility
Age: 50 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. self-reported Native Hawaiian or other Pacific Islander ancestry; 2. ages 50+ but not older than 75 (optimal age range for preventing future dementia in people with cognitive impairment, above 75 is not likely to benefit from this study given their advance age); 3. has subjective cognitive impairment (SCI) or mild cognitive impairment (MCI); 4. have a diagnosis of hypertension, diabetes, dyslipidemia, or obesity (body-mass-index ≥ 30 kg/m2); 5. physically able and willing to engage in moderate physical activity necessary for Hula; and 6. physician's approval to participate in moderate physical activity Exclusion Criteria: 1. currently pregnant; 2. already actively practicing Hula at least once per week; or 3. clinical diagnosis of ADRD (mild to severe); or 4. current diagnosed major depressive disorder at moderate or greater stage, or moderate or greater depression on the Center for Epidemiological Studies Depression Scale (CES-D).
Conditions3
Alzheimer's DiseaseMild Cognitive ImpairmentSubjective Cognitive Impairment
Locations3 sites
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Hawaii
Started2022-09-15
Est. completion2025-06-15
Eligibility
Age50 Years – 75 Years
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT05534607